Search Results
Jaume Capdevila
Jaume Capdevila
Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Desiree’ Deandreis
Desiree’ Deandreis
Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Cosimo Durante
Cosimo Durante
Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Sophie Leboulleux
Sophie Leboulleux
Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Markus Luster
Markus Luster
Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Romana Netea-Maier
Romana Netea-Maier
Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Kate Newbold
Kate Newbold
Royal Marsden Hospital, London, United Kingdom
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Susanne Singer
Susanne Singer
Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Gerasimos P Sykiotis
Gerasimos P Sykiotis
Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Beate Bartes
Beate Bartes
Association “Vivre sans Thyroïde”, Léguevin, France
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Kate Farnell
Kate Farnell
Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Laura Deborah Locati
Laura Deborah Locati
Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
) and parallel treatment options for the progressing lesions (e.g. surgery, EBRT, thermoablation etc.). Depending on the tumor’s molecular profile and the regulatory setting in each country, the clinician can consider prescribing a second-line treatment
